EAU 2011 - Prostate cancer associated up-regulation of AMACR, EZH2 and PSMA correlates with diminished expression of specific microRNAs - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - MicroRNAs (miRNAs) are small pieces of non-coding RNA that were historically thought to have no significant function.

EAU 2011 - Health-related quality of life after salvage high intensity focused ultrasound treatment (HIFU) for locally radiorecurrent prostate cancer - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The study goal was to evaluate health related quality of life (HRQOL) after salvage high intensity focused ultrasound (HIFU) for locally radio-recurrent prostate cancer (CaP).

EAU 2011 - Does biochemical progression after radical prostatectomy and adjuvant radiotherapy for locally advanced prostate cancer invariably impact cancer-specific mortality? - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - This group's objective was to examine the prognosis of patients who experienced biochemical progression (BCR) after adjuvant radiotherapy (aRT) for prostate cancer (CaP).

EAU 2011 - Androstenedione is the most efficient precursor of intraprostatic testosterone production in primary human prostate cancer tissue - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Even with castrate levels of testosterone, the androgen receptor is activated in prostate cancer (CaP) due to several mechanisms.

EAU 2011 - Adjuvant radiotherapy leads to superior biochemical recurrence free survival compared to early salvage radiotherapy in patients with locally advanced prostate cancer: Results of a matched-controlled multi-institutional analysis - Session Highli

VIENNA, AUSTRIA (UroToday.com) - This was a collaborative study among European institutions. Since only about one-third of prostate cancer patients with adverse pathology on radical prostatectomy (RP) benefit from adjuvant radiotherapy (aRT), many urologists choose to monitor sensitive PSA tests and administer early salvage radiotherapy (eSRT) instead.

EAU 2011 - A preoperative serum biomarker panel to identify patients with prostate cancer at high risk of biochemical recurrence following radical prostatectomy - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The intent of this study was to improve upon existing nomograms to predict the likelihood of prostate cancer (CaP) recurrence following radical prostatectomy by integrating biomarkers.

EAU 2011 - Serum levels of pro-inflammatory cytokines immediately increase two days after application of docetaxel in patients with castration-resistant prostate cancer and correlate with apoptosis and clinical response - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - This group sought to further understand the balance of inflammatory and anti-tumoral immune responses in advanced prostate cancer (CaP).

EAU 2011 - Carbon footprint of laparoscopy in the United States - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - This group from Memorial Sloan-Kettering Cancer Center evaluated carbon dioxide, the principal gas used in laparoscopic procedures for insufflation.

EAU 2011 - Differences in biochemical recurrence rate after focal and extensive positive surgical margins following radical prostatectomy - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Level one evidence exists supporting the use of adjuvant radiotherapy following radical prostatectomy (RP) for patients with positive surgical margins (PSMs).

EAU 2011 - Pathologic stage at prostatectomy over time: Has there been a trend toward intervention for localized disease in the robotic era? - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The goal of this study was to assess trends in pathologic stage for patients treated by radical prostatectomy between 1990 and 2010.

Prostate Cancer Highlights

EAU 2011 - Prostate cancer associated up-regulation of AMACR, EZH2 and PSMA correlates with diminished expression of specific microRNAs - Session Highlights

EAU 2011 - Health-related quality of life after salvage high intensity focused ultrasound treatment (HIFU) for locally radiorecurrent prostate cancer - Session Highlights

EAU 2011 - Does biochemical progression after radical prostatectomy and adjuvant radiotherapy for locally advanced prostate cancer invariably impact cancer-specific mortality? - Session Highlights

EAU 2011 - Androstenedione is the most efficient precursor of intraprostatic testosterone production in primary human prostate cancer tissue - Session Highlights

EAU 2011 - Adjuvant radiotherapy leads to superior biochemical recurrence free survival compared to early salvage radiotherapy in patients with locally advanced prostate cancer: Results of a matched-controlled multi-institutional analysis - Session Highli

EAU 2011 - A preoperative serum biomarker panel to identify patients with prostate cancer at high risk of biochemical recurrence following radical prostatectomy - Session Highlights

EAU 2011 - Serum levels of pro-inflammatory cytokines immediately increase two days after application of docetaxel in patients with castration-resistant prostate cancer and correlate with apoptosis and clinical response - Session Highlights

EAU 2011 - Carbon footprint of laparoscopy in the United States - Session Highlights

EAU 2011 - Differences in biochemical recurrence rate after focal and extensive positive surgical margins following radical prostatectomy - Session Highlights

EAU 2011 - Pathologic stage at prostatectomy over time: Has there been a trend toward intervention for localized disease in the robotic era? - Session Highlights

More Articles...

Conferences Menu

Log in

Prostate Cancer Highlights

More Articles...

Conferences Menu